Industry News

Allergan Acquires SkinMedica

Allergan ( has entered into a definitive agreement with SkinMedica ( to acquire the privately held company’s topical aesthetics skincare business. Under the terms of the agreement, Allergan will pay SkinMedica $350 million up-front—subject to certain adjustments—for the business, which includes a variety of physician dispensed non-prescription aesthetic skincare products and prescription products.

BELOTERO BALANCE Now Available Nationwide

Practicing physicians in the United States can now purchase BELOTERO BALANCE (—the latest HA filler to receive FDA approval. BELOTERO BALANCE was approved by the Food and Drug Administration ( in November 2011 as a safe solution for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds and perioral lines. This dermal filler joins Merz Aesthetics' existing portfolio of injectable products, including RADIESSE Volumizing Filler and Asclera (polidocanol) Injection.

Pliaglis Receives FDA Approval

The United States Food and Drug Administration ( has approved a supplemental New Drug Application (sNDA) for topical local anesthetic Pliaglis (lidocaine/tetracaine) 7%/7% Cream. Galderma Laboratories (www., a global pharmaceutical company that specialize in dermatology, will distribute Pliaglis, having licensed worldwide marketing rights from Nuvo Research Inc.

Syneron Home Use Hair Removal Device Approved

Syneron Medical has received 510(k) clearance from the United States Food and Drug Administration ( to market its me Home-Use Hair Removal System to consumers. The me hair removal system is the first and only FDA cleared consumer hair removal technology that is approved for all skin tones. It is also the first home-use product featuring Syneron's proprietary elos technology—which combines intense pulse light (IPL) and radiofrequency (RF) energies—to receive FDA clearance.

AAD Offers Core Curriculum Online

The American Academy of Dermatology has developed a Medical Student Core Curriculum that teaches the fundamental principles of dermatology. The online curriculum—available at—was designed as a companion to clinical dermatology rotations for medical students. It also may be used by educators to assist medical students who are interested in dermatology or by non-dermatologists who are interested in gaining an essential understanding of skin conditions.

Suneva Completes Enrollment for Acne Scar Study

Suneva Medical, a privately held aesthetics company and distributor of Artefill long-term dermal filler, announced that it has completed enrollment and initial treatment of patients in its Phase III acne scar study investigating the efficacy of Artefill for the treatment of moderate to severe atrophic acne scars. The multi-center, prospective study is being conducted at 10 top-tier aesthetic medical practices in the United States.

Allergan Launches New R&D Facility

Allergy has announced the opening of a new 93,000-square-foot research and development center in Bridgewater New Jersey. The state’s Lt. Governor Kim Guadagno, United States Senator Robert Menendez (D-NJ) and state Congressman Leonard Lance joined Allergan president and CEO David E. I. Pyott on September 4, 2012 to mark the grand opening.